BridgeBio Pharma BBIO Capital investments accrued but not yet paid
Capital investments accrued but not yet paid at other companies
Other financials
Where this comes from
Reported directly by BridgeBio Pharma in its filing.
Tagged under the XBRL concept us-gaap:CapitalExpendituresIncurredButNotYetPaid.
The official record: BridgeBio Pharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about BridgeBio Pharma's capital investments accrued but not yet paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BridgeBio Pharma's capital investments accrued but not yet paid?
- BridgeBio Pharma (BBIO) reported capital investments accrued but not yet paid of $12K in Q1 2026.
- How has BridgeBio Pharma's capital investments accrued but not yet paid changed year-over-year?
- BridgeBio Pharma's capital investments accrued but not yet paid decreased by 96.4% year-over-year, from $337K to $12K.